<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01362218</url>
  </required_header>
  <id_info>
    <org_study_id>P-100820-01</org_study_id>
    <nct_id>NCT01362218</nct_id>
  </id_info>
  <brief_title>Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol</brief_title>
  <official_title>Cardiovascular Fixed Combination Pill ASR: Pharmacodynamic Clinical Trial of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril (Cardiovascular Polypill); LDL Cholesterol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferrer Internacional S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferrer Internacional S.A.</source>
  <brief_summary>
    <textblock>
      This study evaluates the effect on LDL cholesterol of the 3 drugs given together in the
      cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin, and ramipril)
      as compared to the effect on LDL cholesterol of the reference products (simvastatin,
      ramipril, acetylsalicylic acid) Approximately 350 subjects will be screened, 266 randomized
      in order about 238 subjects to finish the study.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Per sponsor's decision
  </why_stopped>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in LDL-cholesterol levels between the basal and the final visit of treatment period.</measure>
    <time_frame>Day 56</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>• Difference in VLDL-cholesterol levels between the basal and the final visit of treatment period.</measure>
    <time_frame>Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Difference in HDL-cholesterol levels between the basal and the final visit of treatment period.</measure>
    <time_frame>Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Difference in total cholesterol levels between the basal and the final visit of treatment period.</measure>
    <time_frame>Day 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Difference in triglyceride levels between the basal and the final visit of treatment period</measure>
    <time_frame>Day 56</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">107</enrollment>
  <condition>Elevated LDL Cholesterol</condition>
  <arm_group>
    <arm_group_label>Fixed Dose Combination Pill</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A fixed dose combination of acetylsalicylic acid, simvastatin, and ramipril Intervention: Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simvastatin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Simvastatin given together with the reference drugs ramipril and acetylsalicylic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)</intervention_name>
    <description>A once daily oral dose of the cardiovascular fixed dose combination pill ( acetylsalicylic acid, simvastatin, ramipril) for 8 weeks.</description>
    <arm_group_label>Fixed Dose Combination Pill</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin, ramipril, acetylsalicylic acid</intervention_name>
    <description>A once daily oral dose of simvastatin, ramipril, acetylsalicylic acid for 8 weeks</description>
    <arm_group_label>Simvastatin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects aged ≥18 and &lt;75 years.

          -  Previously untreated or not treated with fibrates during the last 6 weeks or with any
             other lipid lowering drug for the last 4 weeks.

          -  LDL-cholesterol ≥130 and ≤220 mg/dL.

          -  Systolic blood pressure ≥120 and &lt;160 mmHg and diastolic blood pressure ≥70 and &lt;100
             mmHg.

          -  Provide written informed consent.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2011</study_first_submitted>
  <study_first_submitted_qc>May 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2011</study_first_posted>
  <last_update_submitted>April 23, 2013</last_update_submitted>
  <last_update_submitted_qc>April 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
    <mesh_term>Ramipril</mesh_term>
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

